Retraction: Inhibition of δ-opioid receptors induces brain glioma cell apoptosis through the mitochondrial and protein kinase C pathways (Oncology Letters (2013) 6 (1351‑1357) DOI: 10.3892/ol.2013.1546);Inhibition of δ-opioid receptors induces brain glioma cell apoptosis through the mitochondrial and protein kinase C pathways

Oncology Letters

Volumn 6, Issue 5, 2013, Pages 1351-1357

  Zhou, Lixiang ^a   Guo, Xudong ^b   Chen, Mo ^c   Fu, Shuanglin ^a   Zhou, Jingbin ^b   Ren, Gang ^b   Yang, Zirong ^b   Fan, Wenhai ^b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b DALIAN UNIVERSITY   (China)

^c Jilin Province People's Hospital   (China)

Author keywords

Apoptosis; Glioma; Mitochondria; Protein kinase C pathway; opioid receptor

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; DELTA OPIATE RECEPTOR; NALTRINDOLE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOMA; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84884487815     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2023.13768     Document Type: Erratum

References (35)

1. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K and DelattreJY: Primary brain tumours in adults. Lancet 379: 1984-1996, 2012.
2. Johannesen TB, Langmark F and Lote K: Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study. Eur J Cancer 39: 2355-2363, 2003.
3. Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X, Gong Y, Yin B, LiuW, Qiang B, Zhao J, Yuan J and Peng X: MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med (Berl) 87: 43-51, 2009.
4. Komotar RJ, Otten ML, Moise G and Connolly ESJr: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review. Clin Med Oncol 2: 421-422, 2008.
5. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, BogdahnU, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, LacombeD, Cairncross JG, Eisenhauer E and Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
6. Notas G, Kampa M, Nifli AP, Xidakis K, Papasava D, Thermos K, Kouroumalis E and Castanas E: The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors. Eur J Pharmacol 555: 1-7, 2007.
7. Tang B, Li Y, Yuan S, Tomlinson S and He S: Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo. Int J Oncol: July 31, 2013 (Epub ahead of print).
8. Marzioni M, Invernizzi P, Candelaresi C, MaggioniM, Saccomanno S, Selmi C, Rychlicki C, Agostinelli L, CassaniB, Miozzo M, Pasini S, Fava G, Alpini G and Benedetti A: Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth. Dig Liver Dis 41: 523-533, 2009.
9. Heiss A, Ammer H and Eisinger DA: delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation. Exp Cell Res 315: 2115-2125, 2009.
10. Madar I, Bencherif B, Lever J, Heitmiller RF, Yang SC, Brock M, Brahmer J, Ravert H, Dannals R and Frost JJ: Imaging delta-and mu-opioid receptors by PET in lung carcinoma patients. J Nucl Med 48: 207-213, 2007.
11. Debruyne D, Leroy A, DE Wever O, Vakaet L, Mareel M and BrackeM: Direct effects of delta opioid receptor agonists on invasion-associated activities of HCT-8/E11 colon cancer cells. Anticancer Res 30: 9-17, 2010.
12. Zhong J, Kong X, Zhang H, Yu C, Xu Y, Kang J, Yu H, Yi H, YangX and Sun L: Inhibition of CLIC4 enhances autophagy and triggers mitochondrial and ER stress-induced apoptosis in human glioma U251 cells under starvation. PLoS One 7: e39378, 2012.
13. Ordys BB, Launay S, Deighton RF, McCulloch J and WhittleIR: The role of mitochondria in glioma pathophysiology. Mol Neurobiol 42: 64-75, 2010.
14. Zhou J, Cheng G, Cheng G, Tang HF and Zhang X: NovaeguinosideII inhibits cell proliferation and induces apoptosis of human brain glioblastoma U87MG cells through the mitochondrial pathway. Brain Res 1372: 22-28, 2011.
15. Zhang ZF, Guo Y, Zhang JB and Wei XH: Induction of apoptosis by chelerythrine chloride through mitochondrial pathway and Bcl-2 family proteins in human hepatoma SMMC-7721 cell. Arch Pharm Res 34: 791-800, 2011.
16. Du J, Tang B, Wang J, Sui H, Jin X, Wang L and WangZ: Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. Int J Mol Med 29: 607-612, 2012.
17. Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H and WangL: Activation of the δ-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med 28: 1077-1085, 2011.
18. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
19. Chiarugi P and Giannoni E: Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 76: 1352-1364, 2008.
20. Ng CF, Ng PK, Lui VW, Li J, Chan JY, Fung KP, Ng YK, Lai PB and Tsui SK: FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells. Cancer Lett304: 97-106, 2011.
21. Yang TY, Chang GC, Chen KC, Hung HW, Hsu KH, Sheu GT and Hsu SL: Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells. Eur J Pharmacol663: 17-26, 2011.
22. Hatzoglou A, Kampa M and Castanas E: Opioid-somatostatin interactions in regulating cancer cell growth. Front Biosci 10: 244-256, 2005.
23. Kampa M, Bakogeorgou E, Hatzoglou A, Damianaki A, MartinPM and Castanas E: Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol 335: 255-265, 1997.
24. Baldelli B, Vecchio L, Biggiogera M, Vittoria E, Muzzonigro G, Gazzanelli G and Malatesta M: Ultrastructural and immunocytochemical analyses of opioid treatment effects on PC3 prostatic cancer cells. Microsc Res Tech 64: 243-249, 2004.
25. Kerros C, Cavey T, Sola B, Jauzac P and Allouche S: Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells. J Exp Clin Cancer Res28: 77, 2009.
26. Tang B, Du J, Gao ZM, Liang R, Sun DG, Jin XL and WangLM: DADLE suppresses the proliferation of human liver cancer HepG2 cells by activation of PKC pathway and elevates the sensitivity to cis-diammine dichloridoplatium. Zhonghua Zhong Liu Za Zhi 34: 425-429, 2012 (In Chinese).
27. von Haefen C, Wendt J, Semini G, Sifringer M, Belka C, RadetzkiS, Reutter W, Daniel PT and Danker K: Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway. Apoptosis 16: 636-651, 2011.
28. Burlacu A: Regulation of apoptosis by Bcl-2 family proteins. JCell Mol Med 7: 249-257, 2003.
29. Mattson MP and Kroemer G: Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol Med 9: 196-205, 2003.
30. Saito M, Korsmeyer SJ and Schlesinger PH: BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat Cell Biol 2: 553-555, 2000.
31. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, DingCK, Gallant M, Gareau Y, Griffin PR, Labelle M and LazebnikYA: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
32. Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907, 2004.
33. Capiati DA, Vazquez G, Tellez Iñón MT and BolandRL: Antisense oligonucleotides targeted against protein kinasecalpha inhibit proliferation of cultured avian myoblasts. Cell Prolif 33: 307-315, 2000.
34. Ali AS, Ali S, El-Rayes BF, Philip PA and Sarkar FH: Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treat Rev 35: 1-8, 2009.
35. Colombo D, Tringali C, Franchini L, Cirillo F and VenerandoB: Glycoglycerolipid analogues inhibit PKC translocation to the plasma membrane and downstream signaling pathways in PMA-treated fibroblasts and human glioblastoma cells, U87MG. Eur J Med Chem 46: 1827-1834, 2011.